Dr. Foluso Ogunsile’s care for sickle cell patients at Memorial Healthcare System has been deeply concerning and, in many cases, harmful. The Memorial Sickle Cell Home was once a trusted center for individualized, compassionate care, but under Dr. Ogunsile’s leadership, patients report feeling dismissed, stigmatized, and unsafe. Her approach relies heavily on rigid protocols that limit individualized treatment, including labeling patients as “chronic pain patients” without clear criteria, enforcing restrictive oral or patient-controlled analgesia rules, and applying these policies even to those not under her direct care. Many patients have experienced pressure to transition to treatments that are not approved for sickle cell-related pain, leaving them feeling coerced and cornered when their current regimens are altered or reduced. Emergency and chronic pain management is formulaic rather than personalized, which has resulted in delays and inadequate care for life-threatening… complications like acute chest episodes, aplastic crises, or other severe pain crises.
Patients have repeatedly expressed that they are treated with suspicion, often as if they are drug-seeking rather than managing one of the most painful chronic illnesses recognized in medicine. Despite Dr. Ogunsile’s stated personal connection to sickle cell disease through her family, many report a lack of empathy and understanding, experiencing conversations with her team—including her nurse practitioner, pharmacist, and nurse manager—as pressuring and dismissive. These practices have caused many long-standing patients to leave the practice entirely, reduced clinic hours, and created fear and distrust among the sickle cell community. Pediatric patients transitioning to adult care are at particular risk, as they may be referred to a practice where rigid protocols override individualized treatment, and emergency decisions may be delayed by requirements to seek prior approval.
The repeated use of terms describing increased sensitivity to pain due to long-term medication use is often invoked to justify altering effective pain management, leaving patients feeling stigmatized and unheard. Conversations with staff frequently minimize patient concerns about treatment side effects, leaving some to question whether external incentives influence treatment recommendations. Patients report receiving limited alternatives when current regimens are no longer effective, often facing suboptimal care or insufficient pain relief. In emergency situations, reliance on protocol rather than clinical judgment can result in formulaic care, such as administering fluids and oral medications while potentially overlooking serious, life-threatening symptoms. These practices compromise patient safety and trust, particularly in a population that already faces significant barriers to equitable healthcare.
Overall, Dr. Ogunsile demonstrates a troubling combination of inflexibility, poor clinical judgment, and minimal empathy for sickle cell patients. Her protocols and coercive treatment practices have eroded trust, reduced access to effective care, and caused serious distress among patients. Long-standing patients report leaving Memorial Healthcare System entirely, a trend that reflects the inadequacy and danger of her approach. Sickle cell patients deserve hematologists who provide compassionate, individualized care that prioritizes safety and clinical integrity. Dr. Foluso Ogunsile’s practice repeatedly fails these standards, making her unsuitable to serve as a primary hematologist for this vulnerable population. Memorial Healthcare System must take urgent action to ensure that sickle cell patients receive safe, competent, and empathetic care.
Read More